Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
Sanofi sues Sarepta, alleging that Duchenne treatment Elevidys infringes on AAV patents
11 months ago
Manufacturing
Law
Biosecure lawmakers tell trade groups that China studies are a new focus
11 months ago
Deals
China
China corruption crackdown hits Merck’s Gardasil sales, spooking investors
11 months ago
China
Pharma
Keytruda tops $7B quarterly sales for the first time
11 months ago
Pharma
NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class
11 months ago
Deals
R&D
Among pharma CEOs, the IRA now and the IRA later get very different reactions
11 months ago
Pharma
FDA+
EU panel follows FDA’s lead on Wegovy, recommending use to prevent cardiac events
11 months ago
Pharma
FDA+
Sanofi shelves four assets, including mid-stage dwarfism candidate
11 months ago
R&D
Pharma
BioMarin snags expanded Brineura label, now approved for all kids regardless of symptoms
11 months ago
Pharma
FDA+
US bankrolls a third of global Pandemic Fund. Can it get congressional support?
11 months ago
Pharma
Coronavirus
Novartis pays $150M upfront, including $25M in equity, for Dren Bio’s bispecifics
11 months ago
Deals
Updated: Merck, without sharing details, says RSV antibody successfully protected infants
11 months ago
R&D
Pharma
Chinese biotech boasts competitive Phase 2b weight loss data for GLP-1 drug
11 months ago
R&D
Vermont attorney general sues two major PBMs for allegedly driving up costs
11 months ago
Pharma
US inks $113M deal with Siga to bolster smallpox, mpox reserves
11 months ago
Pharma
Roivant recently sold one spinout for billions. Is Priovant next?
11 months ago
Deals
R&D
Nadir Mahmood returns to Nkarta a year after leaving; BeiGene picks longtime Merck exec for CFO post
11 months ago
People
Peer Review
Novartis CEO: Trying to crack obesity market with another first-gen agent is 'not a prudent approach'
11 months ago
R&D
Pharma
Cassava founder and CEO resigns as federal probes progress
11 months ago
People
Federal judge dismisses Hawaii’s lawsuit against top three PBMs
11 months ago
Pharma
Law
Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year
11 months ago
R&D
Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab
11 months ago
Pharma
Lilly says lupus drug dropped from pipeline failed to show efficacy
12 months ago
R&D
Pharma
Indivior axes schizophrenia drug and shrinks revenue guidance
12 months ago
R&D
Pharma
First page
Previous page
10
11
12
13
14
15
Next page
Last page